ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.5402_5406+14del

dbSNP: rs2051069083
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV001187286 SCV001354030 likely pathogenic Hereditary cancer-predisposing syndrome 2021-02-26 criteria provided, single submitter clinical testing The variant causes a 19-nucleotide deletion including the last 5 nucleotides of exon 21 and the first 14 nucleotides of intron 21. This variant is predicted to abolish the intron 21 splice donor site. Although this prediction has not been confirmed in published RNA studies, this variant is expected to result in an absent or disrupted protein product. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of BRCA1 function is a known mechanism of disease. Based on the available evidence, this variant is classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.